Alkermes appoints Dr. Wright to board; two directors retire; new lead independent director

Alkermes plc.

Christopher I. Wright, M.D., Ph.D., appointed to board effective May 24, 2022, bringing neuroscience expertise.
David W. Anstice and Wendy L. Dixon will retire at the 2022 annual meeting; Nancy J. Wysenski named new Lead Independent Director.
Board added seven independent directors since 2019; average tenure dropped from ~6 to ~3 years.
Company engaged with Sarissa Capital in over 20 meetings; declined Sarissa's nominees but appointed Wright after collaboration attempts.
Filing of preliminary proxy statement for 2022 annual meeting; board declassification and plurality voting standard approved.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David W. Anstice AO

Director

ALKS · Alkermes plc.

Filed: May 27, 2022, 7:59 PM ET

David W. Anstice AO and Wendy L. Dixon, Ph.D. notified Alkermes plc (the “Company”) of their decision to retire from the Company’s board of directors (the “Board”) and from any committees of the Board on which they serve

Appointed

Christopher I. Wright

Director

ALKS · Alkermes plc.

Effective: 2022-05-24
Filed: May 27, 2022, 7:59 PM ET

the Board elected Dr. Christopher I. Wright to the Board, effective immediately

Departed

Wendy L. Dixon

Director

ALKS · Alkermes plc.

Filed: May 27, 2022, 7:59 PM ET

David W. Anstice AO and Wendy L. Dixon, Ph.D. notified Alkermes plc (the “Company”) of their decision to retire from the Company’s board of directors (the “Board”) and from any committees of the Board on which they serve

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David W. Anstice AO departed as Director at Alkermes plc..

Action: retire
Role: Director

Exact text from the filing

David W. Anstice AO and Wendy L. Dixon, Ph.D. notified Alkermes plc (the “Company”) of their decision to retire from the Company’s board of directors (the “Board”) and from any committees of the Board on which they serve

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher I. Wright was elected as Director at Alkermes plc..

Action: elected
Role: Director

Exact text from the filing

the Board elected Dr. Christopher I. Wright to the Board, effective immediately

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Wendy L. Dixon departed as Director at Alkermes plc..

Action: retire
Role: Director

Exact text from the filing

David W. Anstice AO and Wendy L. Dixon, Ph.D. notified Alkermes plc (the “Company”) of their decision to retire from the Company’s board of directors (the “Board”) and from any committees of the Board on which they serve

View on SEC.gov

Alkermes plc. filing history →

Source: SEC EDGAR

accession 0001564590-22-021452

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.